The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict HCA Holdings's revenues will increase 3.0% and EPS will wither -2.4%.
The average estimate for revenue is $9.43 billion. On the bottom line, the average EPS estimate is $0.83.
Last quarter, HCA Holdings reported revenue of $9.19 billion. GAAP reported sales were 0.4% higher than the prior-year quarter's $8.41 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.79. GAAP EPS of $0.74 for Q1 were 37% lower than the prior-year quarter's $1.18 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 36.1%, 260 basis points worse than the prior-year quarter. Operating margin was 13.6%, 300 basis points worse than the prior-year quarter. Net margin was 4.1%, 230 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $37.67 billion. The average EPS estimate is $3.16.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 74 members out of 82 rating the stock outperform, and eight members rating it underperform. Among 28 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 27 give HCA Holdings a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on HCA Holdings is outperform, with an average price target of $43.71.
Is HCA Holdings the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add HCA Holdings to My Watchlist.